The Board of Directors of Alembic Pharmaceuticals Limited at its meeting held today has approved the issue of Unsecured Listed Rated Redeemable NonConvertible Debentures (NCDs) of upto Rs. 300 Crores on Private Placement Basis under a shelf disclosure document in one or more tranches and constituted NCD Committee for issue and allotment of NCDs.
Shares of ALEMBIC PHARMACEUTICALS LTD. was last trading in BSE at Rs.502.05 as compared to the previous close of Rs. 498.65. The total number of shares traded during the day was 1383 in over 101 trades.
The stock hit an intraday high of Rs. 505.95 and intraday low of 499.7. The net turnover during the day was Rs. 696204.